- Home
- CALC vs YOSH Comparison
CALC vs YOSH Comparison
Compare CALC & YOSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- YOSH
- Stock Information
- Founded
- CALC 2011
- YOSH 2016
- Country
- CALC United States
- YOSH United States
- Employees
- CALC 15
- YOSH N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- YOSH Restaurants
- Sector
- CALC Health Care
- YOSH Consumer Discretionary
- Exchange
- CALC Nasdaq
- YOSH Nasdaq
- Market Cap
- CALC 22.9M
- YOSH 23.7M
- IPO Year
- CALC N/A
- YOSH 2022
- Fundamental
- Price
- CALC $1.43
- YOSH $9.40
- Analyst Decision
- CALC Strong Buy
- YOSH
- Analyst Count
- CALC 3
- YOSH 0
- Target Price
- CALC $16.33
- YOSH N/A
- AVG Volume (30 Days)
- CALC 22.6K
- YOSH 6.1K
- Earning Date
- CALC 08-11-2025
- YOSH 08-18-2025
- Dividend Yield
- CALC N/A
- YOSH N/A
- EPS Growth
- CALC N/A
- YOSH N/A
- EPS
- CALC N/A
- YOSH N/A
- Revenue
- CALC N/A
- YOSH $13,539,317.00
- Revenue This Year
- CALC N/A
- YOSH N/A
- Revenue Next Year
- CALC N/A
- YOSH N/A
- P/E Ratio
- CALC N/A
- YOSH N/A
- Revenue Growth
- CALC N/A
- YOSH 41.82
- 52 Week Low
- CALC $1.43
- YOSH $2.71
- 52 Week High
- CALC $5.97
- YOSH $22.50
- Technical
- Relative Strength Index (RSI)
- CALC 32.78
- YOSH 30.44
- Support Level
- CALC $1.48
- YOSH $8.95
- Resistance Level
- CALC $1.79
- YOSH $14.31
- Average True Range (ATR)
- CALC 0.12
- YOSH 0.84
- MACD
- CALC -0.02
- YOSH -0.40
- Stochastic Oscillator
- CALC 0.00
- YOSH 8.46
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About YOSH Yoshiharu Global Co.
Yoshiharu Global Co is a restaurant operator. The company has one reportable segment, consisting of operating its stores. Yoshiharu serves the perfect, ideal ramen, as well as offers customers a wide variety of sushi, bento menus, and other favorite Japanese cuisines. It owns and operates restaurant stores.